Drug Discovery Informatics Market, By Function (Docking, Sequencing and Target Data Analysis, Molecular Modelling, Library & Database Preparation, Other functions), By Solution (Software, Services), By Application (Drug Discovery, Drug Development), By End-user: (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), Other End Users), By Region – Global Analysis Forecast Till 2030

The Global Drug Discovery Informatics Market accounted for US$ 2.5 billion in 2020 and is estimated to be US$ 5.2 billion by 2030 and is anticipated to register a CAGR of 9.1%.

A technology known as drug discovery informatics produces enormous volumes of data and knowledge about illnesses and medications that may be used in research and development. It is frequently applied to improve drug compound screening. The process of creating new drugs is accelerated by drug discovery informatics, which produces precise, real-time data. One of the key factors fueling the growth of the target drug discovery informatics market is the rise of chronic disorders like cancer, diabetes, etc.

Market Dynamics:

Drivers:

The introduction of in silico tools, enabling calculations with diverse workflows synchronized with the speed of modern medicinal chemistry is one of the major drifts motivating target market growth. Drug discovery is a practical procedure in pharmaceutical and biotechnology companies. This includes various steps and procedures that rely on in-silico tools to reduce the complexity of the process. Identification of lead molecules requires the analysis and synthesis of numerous derivatives that can be designed using in-silico modeling tools.

The success of drug discovery experiments largely depends on the effectiveness of the tools used to measure various aspects of a drug. For example, the in-silico tool used herein can be used to determine the 3D structure of protein-ADMET assessment-affinity and ligand estimation in docking for drug-ligand interactions and pharmacological profiling which Includes modeling tools.

Restraints:

Advances in the underlying algorithms used in computational information processing for predictive chemistry are primarily aimed at revitalizing the global drug discovery informatics market over the next few years. These advances help advance scientific innovation and laboratory informatics.

However, high installation costs and a lack of trained and skilled professionals are restraining the growth of drug discovery informatics market to some extent. In addition, intellectual property protection and public policy issues coupled with the existence of open-source software packages for drug discovery are hampering the growth of the global drug discovery informatics market.

Key players:

• Albany Molecular Research, Inc.,

• Certara,

• Collaborative Drug Discovery, Inc.,

• Charles River Laboratories,

• Infosys,

• Boehringer Ingelheim GmBh,

• GVK Biosciences,

• DiscoverX,

• ChemAxon,

• and Jubilant Biosys

• And Others

Market Segmentation:

Drug Discovery Informatics Market, By Solution:

• Software

• Services

Drug Discovery Informatics Market, By Function:

• Sequencing and Target Data Analysis

• Docking

• Molecular Modelling

• Library & Database Preparation

• Other functions

Drug Discovery Informatics Market, By Application:

• Drug Discovery

• Drug Development

Drug Discovery Informatics Market, By End-user:

• Pharmaceutical Companies

• Biotechnology Companies

• Contract Research Organization (CROs)

• Other End Users

Drug Discovery Informatics Market, By Geography

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

• Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Malaysia

  • Philippines

• Latin America

  • Brazil

  • Rest of Latin America

• Middle East & Africa (MEA)

  • GCC

  • North Africa

  • South Africa

  • Rest of Middle East & Africa

Regional Analysis:

In 2020, North America held the greatest market share of XX%. Numerous aspects, including the high prevalence of infectious diseases, the quick uptake of new and sophisticated instruments for R&D, and the presence of major players, can be blamed for the region's expansion. Companies in the area are also concentrating on joint ventures and research partnerships, which will drive Drug Discovery Informatics Market expansion in the upcoming years.

Atomwise Inc., for instance, presented its expanding portfolio of collaborative ventures in December 2020. These programs included infectious diseases, immunology, oncology, coagulation disorders, and neuroscience, and included vAirus, OrganAi, and A2i Therapeutics. The fastest-growing geographical Drug Discovery Informatics Market is anticipated to be Asia Pacific between 2021 and 2030.

Scope Of the Report:

User

Tab Content